EMEA-000877-PIP03-17-M03

Table of contents

Key facts

Invented name
Exparel liposomal
Active substance
bupivacaine
Therapeutic area
Pain
Decision number
P/0342/2021
PIP number
EMEA-000877-PIP03-17-M03
Pharmaceutical form(s)
  • Suspension for injection
  • Prolonged-release dispersion for injection
Condition(s) / indication(s)
Postsurgical analgesia
Route(s) of administration
  • Perineural use
  • Infiltration use
Contact for public enquiries
Pacira Ltd

Tel.  +1 9732544600
E-mail: expareleurope@pacira.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating